Medtronic veteran named CEO of medtech startup Versa Vascular | Cardiovascular Business
NEW34 days ago|Discuss (0)|Business
Article written by Cardiovascular Business
Versa Vascular has appointed Bill Shields as its new CEO, succeeding David Hovda who is retiring but will remain as an advisor. The company has successfully raised $42 million in Series C funding to support the development of its transcatheter tricuspid repair device.
Read full story @ cardiovascularbusiness.com/topics/clinical/structural-heart-disease/medtronic-veteran-named-ceo-medtech-startup-versa-vascular »
NewzGrade: 90 [A-]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
90A-
FDCBA
SPAG95
Coherent90
Objective90
Sourced90
Concise85
Graded by NewzGrade AI AI · provisional on August 14, 2026 at 03:48 AM
90A-
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 95 | 90 | 90 | 90 | 85 |
90A-grade breakdown
SPAG
95
Coherent
90
Objective
90
Sourced
90
Concise
85
This article is classified as news and performs well in terms of clarity and factual reporting, with minor improvements possible in concise expression. It effectively covers the appointment of a new CEO for Versa Vascular and relevant company developments.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
